106 related articles for article (PubMed ID: 7828622)
1. Serum amylase and tissue polypeptide antigen as biochemical indicators of salivary gland injury during iodine-131 therapy.
Becciolini A; Porciani S; Lanini A; Benucci A; Castagnoli A; Pupi A
Eur J Nucl Med; 1994 Oct; 21(10):1121-5. PubMed ID: 7828622
[TBL] [Abstract][Full Text] [Related]
2. Proposal for biochemical dosimeter for prolonged space flights.
Becciolini A; Porciani S; Lanini A; Balzi M; Faraoni P
Phys Med; 2001; 17 Suppl 1():185-6. PubMed ID: 11776255
[TBL] [Abstract][Full Text] [Related]
3. Marker determination for response monitoring: radiotherapy and disappearance curves.
Becciolini A; Porciani S; Lanini A
Int J Biol Markers; 1994; 9(1):38-42. PubMed ID: 7519652
[TBL] [Abstract][Full Text] [Related]
4. Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer.
Jentzen W; Schneider E; Freudenberg L; Eising EG; Görges R; Müller SP; Brandau W; Bockisch A
Nucl Med Commun; 2006 Aug; 27(8):669-76. PubMed ID: 16829767
[TBL] [Abstract][Full Text] [Related]
5. [Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report].
Macioszek A; Baczyk M; Kopeć T; Sowiński J
Endokrynol Pol; 2008; 59(5):403-10. PubMed ID: 18979451
[TBL] [Abstract][Full Text] [Related]
6. The Preventive Effect of Parotid Gland Massage on Salivary Gland Dysfunction During High-Dose Radioactive Iodine Therapy for Differentiated Thyroid Cancer: A Randomized Clinical Trial.
Son SH; Lee CH; Jung JH; Kim DH; Hong CM; Jeong JH; Jeong SY; Lee SW; Lee J; Ahn BC
Clin Nucl Med; 2019 Aug; 44(8):625-633. PubMed ID: 31274608
[TBL] [Abstract][Full Text] [Related]
7. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer.
Son H; Lee SM; Yoon RG; Lee H; Lee I; Kim S; Chung WY; Lee JW
Hell J Nucl Med; 2017; 20(1):62-70. PubMed ID: 28315910
[TBL] [Abstract][Full Text] [Related]
8. Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.
Liu B; Huang R; Kuang A; Zhao Z; Zeng Y; Wang J; Tian R
Med Phys; 2011 Oct; 38(10):5412-9. PubMed ID: 21992360
[TBL] [Abstract][Full Text] [Related]
9. [Salivary gland scintigraphy after radio-iodine therapy. Functional scintigraphy of the salivary gland after high dose radio-iodine therapy (author's transl)].
Albrecht HH; Creutzig H
Rofo; 1976 Dec; 125(6):546-51. PubMed ID: 137852
[TBL] [Abstract][Full Text] [Related]
10. Serum tissue polypeptide antigen (TPA): a marker of acute injury of salivary glands during radiation therapy.
Becciolini A; Tommasi MS; Porciani S; Fantappiè B; Cellai E; Chiavacci A
Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1339-42. PubMed ID: 3624042
[TBL] [Abstract][Full Text] [Related]
11. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum and salivary amylase during radiotherapy for head and neck cancer: a comparison of conventionally fractionated radiotherapy with CHART.
Leslie MD; Dische S
Radiother Oncol; 1992 May; 24(1):27-31. PubMed ID: 1377830
[TBL] [Abstract][Full Text] [Related]
13. Pilocarpine effect on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine.
Haghighatafshar M; Ghaedian M; Etemadi Z; Entezarmahdi SM; Ghaedian T
Nucl Med Commun; 2018 May; 39(5):430-434. PubMed ID: 29517578
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland toxicity after radioiodine therapy for thyroid cancer.
Hyer S; Kong A; Pratt B; Harmer C
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):83-6. PubMed ID: 17305259
[TBL] [Abstract][Full Text] [Related]
15. Plasma amylase activity as a biochemical indicator of radiation injury to salivary glands.
Becciolini A; Giannardi G; Cionini L; Porciani S; Fallai C; Pirtoli L
Acta Radiol Oncol; 1984; 23(1):9-14. PubMed ID: 6203336
[TBL] [Abstract][Full Text] [Related]
16. Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma.
Ish-Shalom S; Durleshter L; Segal E; Nagler RM
Eur J Endocrinol; 2008 May; 158(5):677-81. PubMed ID: 18426826
[TBL] [Abstract][Full Text] [Related]
17. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?
Fallahi B; Beiki D; Abedi SM; Saghari M; Fard-Esfahani A; Akhzari F; Mokarami B; Eftekhari M
Nucl Med Commun; 2013 Aug; 34(8):777-86. PubMed ID: 23708871
[TBL] [Abstract][Full Text] [Related]
18. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine.
Malpani BL; Samuel AM; Ray S
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):535-40. PubMed ID: 8655377
[TBL] [Abstract][Full Text] [Related]
19. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial.
Liu B; Kuang A; Huang R; Zhao Z; Zeng Y; Wang J; Tian R
J Nucl Med; 2010 Apr; 51(4):618-23. PubMed ID: 20237029
[TBL] [Abstract][Full Text] [Related]
20. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.
Solans R; Bosch JA; Galofré P; Porta F; Roselló J; Selva-O'Callagan A; Vilardell M
J Nucl Med; 2001 May; 42(5):738-43. PubMed ID: 11337569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
